TNET Stock Analysis: TriNet | NYSE
Staffing & Employment Services | NYSE, USA | Market Cap: 3.226m USD | 12M Return: 1% | US8962881079 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 23.4M
EPS Trend: -85.4%
Qual. Beats: 2
Rev. Trend: 17.6%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
TriNet Group, Inc. (NYSE: TNET) is a U.S.-based provider of human capital management services focused on small and medium-sized businesses. Its offerings span payroll processing, tax administration, employee benefits (health insurance and retirement plans), workers compensation, HR compliance, and an online technology platform for managing HR transactions and workforce analytics. The company serves clients across technology, professional services, financial services, life sciences, and not-for-profit industries, selling primarily through a direct sales force. Founded in 1988 and headquartered in Dublin, California, TriNet has been publicly traded since its 2014 IPO.
The company operates as a Professional Employer Organization (PEO), a business model in which the PEO enters into a co-employment relationship with client companies, sharing employer responsibilities for the clients workforce. This model allows SMBs to outsource back-office HR functions and access employee benefits typically available only to larger employers. TriNet competes within the GICS Human Resource & Employment Services sub-industry alongside other major PEOs such as Insperity, ADP TotalSource, and Paychex.
- Worksite employee growth drives recurring HR services revenue
- Health insurance claims pressure gross margins on benefits pass-through
- SMB hiring slowdown reduces payroll processing volume
| Net Income: 175.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -7.45 > 1.0 |
| NWC/Revenue: 5.63% < 20% (prev 4.99%; Δ 0.64% < -1%) |
| CFO/TA 0.11 > 3% & CFO 370.0m > Net Income 175.0m |
| Net Debt (646.0m) to EBITDA (379.0m): 1.70 < 3 |
| Current Ratio: 1.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (47.0m) vs 12m ago -4.08% < -2% |
| Gross Margin: 19.10% > 18% (prev 18.42%; Δ 0.69% > 0.5%) |
| Asset Turnover: 138.9% > 50% (prev 138.1%; Δ 0.77% > 0%) |
| Interest Coverage Ratio: 5.59 > 6 (EBIT TTM 302.0m / Interest Expense TTM 54.0m) |
| A: 0.08 (Total Current Assets 2.38b - Total Current Liabilities 2.11b) / Total Assets 3.35b |
| B: -0.31 (Retained Earnings -1.05b / Total Assets 3.35b) |
| C: 0.09 (EBIT TTM 302.0m / Avg Total Assets 3.52b) |
| D: 0.04 (Book Value of Equity 125.0m / Total Liabilities 3.22b) |
| Altman-Z'' = 0.14 = B |
| DSRI: 0.90 (Receivables 431.0m/499.0m, Revenue 4.88b/5.09b) |
| GMI: 0.96 (GM 18.42% / 19.10%) |
| AQI: 1.12 (AQ_t 0.27 / AQ_t-1 0.24) |
| SGI: 0.96 (Revenue 4.88b / 5.09b) |
| TATA: -0.06 (NI 175.0m - CFO 370.0m) / TA 3.35b) |
| Beneish M = -3.10 (Cap -4..+1) = AA |
As of September 01, 2026, the stock is trading at USD 70.29 with a total of 398,994 shares traded. Over the past week, the price has changed by +0.99%, over one month by +6.78%, over three months by +44.53% and over the past year by +0.96%.
Current recommended Stop Loss: 67.10 (which is 4.5% or 1.2 ATR below the current price).
TriNet has received a consensus analysts rating of 3.43. Therefore, it is recommended to hold TNET.
- StrongBuy: 2
- Buy: 0
- Hold: 4
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 66.2 | -5.8% |
P/E Trailing = 18.6393
P/E Forward = 7.9239
P/S = 0.6683
P/B = 25.5341
P/EG = 7.216
Revenue TTM = 4.88b USD
EBIT TTM = 302.0m USD
EBITDA TTM = 379.0m USD
Long Term Debt = 896.0m USD (from longTermDebt, last quarter)
Short Term Debt = 10.0m USD (from shortTermDebt, last quarter)
Debt = 1.00b USD (from shortLongTermDebtTotal, last quarter) + Leases 54.0m
Net Debt = 646.0m USD (calculated: Debt 1.00b - CCE 358.0m)
Enterprise Value = 3.87b USD (3.23b + Debt 1.00b - CCE 358.0m)
Interest Coverage Ratio = 5.59 (Ebit TTM 302.0m / Interest Expense TTM 54.0m)
EV/FCF = 11.26x (Enterprise Value 3.87b / FCF TTM 344.0m)
FCF Yield = 8.88% (FCF TTM 344.0m / Enterprise Value 3.87b)
FCF Margin = 7.04% (FCF TTM 344.0m / Revenue TTM 4.88b)
Net Margin = 3.58% (Net Income TTM 175.0m / Revenue TTM 4.88b)
Gross Margin = 19.10% ((Revenue TTM 4.88b - Cost of Revenue TTM 3.95b) / Revenue TTM)
Gross Margin QoQ = 20.88% (prev 24.47%)
Tobins Q-Ratio = 1.16 (Enterprise Value 3.87b / Total Assets 3.35b)
Interest Expense / Debt = 5.38% (Interest Expense 54.0m / Debt 1.00b)
Taxrate = 29.44% (73.0m / 248.0m)
NOPAT = 213.1m (EBIT 302.0m * (1 - 29.44%))
Current Ratio = 1.13 (Total Current Assets 2.38b / Total Current Liabilities 2.11b)
Debt / Equity = 8.03 (Debt 1.00b / totalStockholderEquity, last quarter 125.0m)
Debt / EBITDA = 1.70 (Net Debt 646.0m / EBITDA 379.0m)
Debt / FCF = 1.88 (Net Debt 646.0m / FCF TTM 344.0m)
Total Stockholder Equity = 93.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.98% (Net Income 175.0m / Total Assets 3.35b)
RoE = 188.2% (Net Income TTM 175.0m / Total Stockholder Equity 93.0m)
RoCE = 30.54% (EBIT 302.0m / Capital Employed (Equity 93.0m + L.T.Debt 896.0m))
RoIC = 21.25% (NOPAT 213.1m / Invested Capital 1.00b)
WACC = 5.10% (E(3.23b)/V(4.23b) * Re(5.51%) + D(1.00b)/V(4.23b) * Rd(5.38%) * (1-Tc(0.29)))
Discount Rate = 5.51% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.47 | Cagr: -3.57%
[DCF] Terminal Value 73.10% ; FCFF base≈468.0m ; Y1≈410.4m ; Y5≈331.6m
[DCF] Fair Price = 101.9 (EV 5.32b - Net Debt 646.0m = Equity 4.68b / Shares 45.9m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -85.40 | EPS CAGR: -16.95% | SUE: 2.34 | # QB: 2
Revenue Correlation: 17.56 | Revenue CAGR: 0.31% | SUE: -0.00 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.60 | Chg30d=-27.52% | Revisions=-62% | Analysts=7
EPS current Year (2026-12-31): EPS=4.85 | Chg30d=+6.37% | Revisions=+62% | GrowthEPS=+2.6% | GrowthRev=-3.9%
EPS next Year (2027-12-31): EPS=4.91 | Chg30d=+1.27% | Revisions=+29% | GrowthEPS=+1.1% | GrowthRev=+3.8%
[Analyst] Revisions Ratio: +12% (up=8, down=6)